Clinical Scorecard: Your Biological Age? It's in the Blood

At a Glance

Key Highlights

• A panel of 10 sex-specific blood biomarkers estimates biological age more accurately than chronological age.
• Biological age difference (biological minus chronological age) provides a more informative metric for aging and disease risk.
• Certain biomarkers (HDL cholesterol, 25-hydroxyvitamin D, CD3+ CD4+/CD45+ T-cell ratios) correlate with younger biological age, while others (glucose, HbA1c) track chronological age but not biological aging.

Guideline-Based Recommendations

Diagnosis

• Use multi-marker blood panels rather than single analytes to assess biological aging.
• Apply sex-specific algorithms for biological age estimation.

Management

• Incorporate biological age metrics to guide personalized preventive strategies and early identification of age-related disease risk.

Monitoring & Follow-up

• Monitor changes in biological age over time using integrated biomarker panels to evaluate intervention effectiveness.

Risks

• Recognize that biological age may differ from chronological age in conditions such as Down syndrome, smoking, and hormone replacement therapy.

Patient & Prescribing Data

Adults aged 35-74, including subgroups with accelerated or decelerated biological aging

Biological age metrics may inform personalized prevention and monitoring but require further validation before routine clinical use.

Clinical Best Practices

• Employ multi-marker blood biomarker panels for a comprehensive assessment of physiological aging.
• Use sex-specific algorithms to improve accuracy of biological age estimation.
• Interpret biological age difference to identify individuals at increased risk for age-related diseases.
• Consider integrating clinical chemistry, immunological, and molecular data for robust aging assessment.
• Recognize the potential of biological age metrics to guide personalized preventive care across the lifespan.

References

• European MARK-AGE Study